Document is current

Any future updates will be listed below

Retraction Note: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axis

Crossref DOI link: https://doi.org/10.1038/s41598-025-11770-9

Published Online: 2025-07-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark